Hibiscus BioVentures

Hibiscus BioVentures

Rockville, Marylandhibiscusbio.com

Overview

Hibiscus BioVentures is a venture capital firm and startup studio founded in 2019 and based in Rockville, Maryland. The firm is dedicated to advancing patient care by building and investing in companies focused on transformative technologies and commercially viable therapies in the biotechnology and pharmaceutical sectors. Hibiscus BioVentures operates through two distinct arms: Hibiscus Biotechnology (HBT), LLC, a venture studio that builds companies from the ground up, and Hibiscus Capital Management (HCM), LLC, a venture capital firm that invests in early-stage biotechnology companies. The firm's investment portfolio includes companies in life sciences, often at the Series A stage.

Portfolio Companies

3

Investments

CompanyDateStageLead
AsclepiX TherapeuticsJul 2023Series A ExtensionCo-investor
Cellevolve BioNov 2021SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersRockville, Maryland
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.